Nasal cartilage grafts: more than a decade of experience.
From 1985 to 1995, a total of 311 patients underwent nasoplasties. During this time period, the number of patients receiving grafts increased from 94 percent in 1985-1989 to 100 percent in 1993-1995. The donor grafts averaged 72 percent nasal cartilage, 10 percent conchal cartilage, 9 percent fascia, and 9 percent rib allograft. Graft recipient sites averaged 41 percent in the tip, 31 percent in the dorsum, 17 percent in the columella, and 3 percent in the region of the lower lateral cartilage; 8 percent were spreader grafts. During this time frame, tip grafting increased from 34 percent in 1985-1989 to 54 percent in 1993-1995. Reoperation for complications decreased from 17 percent in 1985-1989 to 2 percent in 1993-1995. During the time span examined, the use of rib allografts declined, the use of autologous cartilage increased, the use of onlay tip grafts increased, and the incidence of reoperations declined. Early in the series, 80 percent of the malplaced tips were shield type grafts. With the use of the onlay tip graft, the complication of a malpositioned tip has been substantially diminished. The increased use of crushed cartilage has resulted in improvement in results and patient satisfaction, as it serves to camouflage slight irregularities in the tip and dorsum of the nose.
Collawn
S S
SS
University of Alabama at Birmingham, 35294-3295, USA.
Fix
R J
RJ
Moore
J R
JR
Vasconez
L O
LO
D016025:Bone Transplantation / Q000379:methods; D002356:Cartilage / Q000637:transplantation*; D004954:Esthetics; D005205:Fascia / Q000637:transplantation; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D015994:Incidence; D009300:Nasal Septum / Q000601:surgery; D009666:Nose / Q000473:pathology / Q000601:surgery; D017060:Patient Satisfaction; D012086:Reoperation; D012189:Retrospective Studies; D012225:Rhinoplasty / Q000009:adverse effects / Q000145:classification / Q000379:methods*; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D016896:Treatment Outcome